Beam stock forecast.
Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years.
Find the latest Beam Therapeutics Inc. BEAM analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.This is where a guiding hand from Wall Street’s pros comes in handy. The stock experts at banking giant Wells Fargo have identified two names whose share price is down over 50% this year ...$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. Analyst Consensus: Buy * Price targets were last updated on Oct 17, 2023. Analyst RatingsHere are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ...
According to our current BEAM stock forecast, the value of Beam Therapeutics shares will drop by -2.93% and reach $ 28.70 per share by December 8, …Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.44M. -19.71%. Get the latest Beam Global (BEEM) real-time quote ...Next reporting date. February 14, 2024. EPS forecast (this quarter) $0.29. Annual revenue (last year) $11.1B. Annual profit (last year) $432.0M. Net profit margin.
Fiscal Q3 2023 ended 9/30/23. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading...
Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... Stock Forecast for the Price of an Beam Therapeutics Share in Feb 2025. In February 2025, analysts believe the stock price will be $21.97. An increase of 15.15% compared to the previous month's estimate.Find the latest UiPath Inc. (PATH) stock quote, history, news and other vital information to help you with your stock trading and investing.The Beam Therapeutics Inc. stock price gained 5.44% on the last trading day (Wednesday, 22nd Nov 2023), rising from $27.95 to $29.47. During the last trading day the stock fluctuated 5.68% from a day low at $28.24 to a day high of $29.84. The price has been going up and down for this period, and there has been a 28.69% gain for the last 2 weeks.According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. Analyst Consensus: Buy * Price targets were last updated on Oct 17, 2023. Analyst Ratings
View the real-time BEAM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...
TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com
Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Nov 29, 2023 · According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Schrodinger Inc have a median target of 47.00, with a high estimate of 80.00 and a low estimate of 29.00. The median ...Find real-time HAL - Halliburton Co stock quotes, company profile, news and forecasts from CNN Business.
Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A …Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ...The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion proNov 29, 2023 · Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80 Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ...See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Perform stock investment research with our IBD research tools to help investment strategies. We provide the resources to help make informed decisions.Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...
Open the BEAM Page at The Online Investor (in a new window) » List of Beverages & Wineries Mergers & Acquisitions in this Slideshow:. 10/3/2012: Acquirer: Crystal Rock Holdings, Inc. (CRVP) Acquiree: Frontenac Crystal Springs and Girard Water Company Merger/Acquisition details: details » 12/14/2012: Acquirer: Coca-Cola FEMSA (KOF) …Find the latest Altimmune, Inc. (ALT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Nov 30, 2023 · Beam Therapeutics Inc. (BEAM) Stock Price, Quote & News - Stock Analysis 29.67 +0.20 (0.68%) At close: Nov 24, 2023, 1:00 PM 30.22 +0.55 (1.85%) After-hours: Nov 24, 2023, 4:42 PM EST Overview Financials Statistics Profile Chart 1Y Max 0.68% ( 1D) About BEAM Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Tangshan Factory Hot Rolled Steel Profile H Beam I Beam with Stock Price, Find Details about Steel H Beam, H Beam from Tangshan Factory Hot Rolled Steel ...Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes, company profile, news and forecasts from CNN Business.
Jun 12, 2022 · Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ...
Find real-time DDOG - Datadog Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.32: Annual revenue (last year) $1.7B: Annual profit (last ...
(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...Find the latest UiPath Inc. (PATH) stock quote, history, news and other vital information to help you with your stock trading and investing.7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …Inflation and geopolitical conflicts remain risks for investors. The stock market is entering the end of 2023 with major positive momentum, including an eight-day winning streak for the S&P 500 in ...Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ... Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …Find real-time HAL - Halliburton Co stock quotes, company profile, news and forecasts from CNN Business.Nov 22, 2023 · Beam Global Stock Forecast and Price Target. In recent months, notable analysts have provided yearlong price targets for Beam Global, with the average target coming in at $18.00. If it were to be achieved, this would result in a potential upside of approximately 222 percent from the most recent closing price in November, 2023. 0.99%. €17.62M. IBAB | Complete Ion Beam Applications S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com
GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.According to analyst projections, BEAM’s forecast low is $19.00 with $95.00 as the target high. To hit the forecast high, the stock’s price needs a -219.33% plunge from its current level, while the stock would need to tank 36.13% for it to hit the projected low. Beam Therapeutics Inc (BEAM) estimates and forecastsThis is where a guiding hand from Wall Street’s pros comes in handy. The stock experts at banking giant Wells Fargo have identified two names whose share price is down over 50% this year ...Chronic organ damage is the leading cause of death in adults with SCD. Beam is advancing multiple base editing programs for sickle cell disease, led by Beam-101, an ex vivo cell therapy in which cells are collected from a patient, edited, and then infused back into the patient. To create space for the edited cells to take hold in the bone ...Instagram:https://instagram. kre etfvenezuela etfreviews on birch gold groupwhere can i purchase credit life insurance Find real-time NIO - NIO Inc stock quotes, company profile, news and forecasts from CNN Business. vanguard emerging market etfvalue of 1921 liberty silver dollar The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)Apr 18, 2023 · Also, the market prices MUSA at a forward multiple of 11.67, below the sector median value of 15.34 times. Thus, MUSA at least ranks as one of the stocks to watch. Finally, Wall Street analysts ... stocks with strong buy ratings today 11 brokers have issued 12 month price objectives for Beam Therapeutics' stock. Their BEAM share price targets range from $20.00 to $105.00. On average, they …Q: Investment web sites such as Yahoo list one-year price targets for stocks. How often are these correct? — Hal A: Simply put, these numbers… By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its par...